期刊文献+

尿路感染病原菌分布及耐药性 被引量:21

Distribution and drug resistance of pathogens causing urinary tract infections
原文传递
导出
摘要 目的了解医院尿路感染病原菌分布及耐药性,为临床用药提供依据。方法按照常规培养方法分离病原菌,采用法国生物梅里埃公司API鉴定系统及K-B琼脂扩散法对病原菌进行鉴定及药物敏感试验,应用WHONET5.5软件分析病原菌分布及耐药性。结果 930株尿路感染主要病原菌中,革兰阴性杆菌574株占61.7%,革兰阳性球菌234株占25.2%,真菌122株占13.1%;耐甲氧西林金黄色葡萄球菌(MRSA)及耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)检出率分别为8.5%、10.3%;大肠埃希菌及肺炎克雷伯菌中产超广谱β-内酰胺酶(ESBLs)检出率为19.8%、14.7%。结论大肠埃希菌是尿路感染的主要病原菌,真菌感染及细菌多药耐药是医院面临的重要问题,临床上应根据体外药敏结果选择抗菌药物,控制耐药菌株的产生。 OBJECTIVE To explore the distribution and drug resistance of the pathogens causing urinary tract infections so as to provide evidence for clinical application of antibiotics. METHODS The pathogens were isolated and identified by routine methods. The identification of the pathogens and the drug susceptibility testing were performed by Kirby-Bauer methods, and the distribution of the pathogens and the drug resistance were analyzed by WHONET5.5 software. RESULTS Of 930 strains of pathogens causing urinary tract infections, there were 574 (61.7 %) strains of gram-negative bacilli, 234 (25.2%) strains of gram-positive cocci, and 122 (13.1 %) strains of fungi; the detection rates of MRSA and MRCNS were 8. 5% and 10.3M, respectively; the detection rates of extended-spectrum 13-1actamases (ESBLs)-producing Escherichia coli and Klebsiella pneumoniae were 19.8% and 14.7%, respectively. CONCLUSION E. coli is the main pathogen causing urinary tract infections. The hospital faces the main problems like fungal infections and multidrug-resistance, it is necessary to control the drug resistant strains in accordance with in vitro drug susceptibility testing.
作者 石岚 杨媛
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第15期3413-3415,共3页 Chinese Journal of Nosocomiology
关键词 尿路感染 病原菌 耐药性 Urinary tract infection Pathogenic bacteria Drug resistance
  • 相关文献

参考文献2

二级参考文献13

  • 1燕成岭,樊淑珍,曹银芳,李凤娥.泌尿系感染的病原菌分布及耐药性分析[J].中华医院感染学杂志,2007,17(2):224-226. 被引量:35
  • 2张璟,孙自镛,马越,李景云,金少鸿.152株肺炎链球菌的耐药性及血清分型研究[J].中华医院感染学杂志,2007,17(4):468-471. 被引量:36
  • 3Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Eighteenth informational supplement. CIGI documents M100-S18. CLSI/NCCLS,2008.
  • 4Granger D, Boily-Larouche G, Turgeon P, et al. Molecular characteristics of pbpla and pbp2b in clinical Streptococcus pneurnoniae isolates in Quebec. Canada[J]. J Antimierob Chemoter,2006,57(1):61-70.
  • 5Schwaber MJ, Navon-Venezia S, Kaye KS, et al. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamases-producing Enterobacteriaeeae[J]. Antimierob Agents Chemother, 2006,50(4) : 1257-1262.
  • 6Tumbarello M, Spanu T, Sanguinetti M, et al. Bloodstream infections caused by extended-spectrum-β-lactamases-producing Klebsiella pneumoniae :risk factors, molecular epidemiol- ogy and clinical outcome[J]. Antimicrob Agents Chemother, 2006,50(2):498 504.
  • 7Wang H, Kelkar S, Wu WY, etal. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases:prevalence of CTX-M 3 at a hospital in China[J]. Antimicrob Agents Chemother, 2003,47(2) : 790-793.
  • 8Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Seventh edition. Approved Standard. CLSI documents M7 A7. CLSI,2006.
  • 9叶应妩,王毓久,申子瑜,等.全国临床检验操作规程[M].第3版.北京:中华人民共和国卫生部,2006.
  • 10顾俊明,李家泰,王镇山,薛欣.2004-2005年住院患者细菌耐药监测研究[J].中华检验医学杂志,2008,31(6):615-622. 被引量:56

共引文献312

同被引文献136

引证文献21

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部